Cargando…
Engineered Tissue for Cardiac Regeneration: Current Status and Future Perspectives
Heart failure (HF) is the leading cause of death worldwide. The most effective HF treatment is heart transplantation, the use of which is restricted by the limited supply of donor hearts. The human pluripotent stem cell (hPSC), including human embryonic stem cell (hESC) and the induced pluripotent s...
Autores principales: | Li, Junjun, Liu, Li, Zhang, Jingbo, Qu, Xiang, Kawamura, Takuji, Miyagawa, Shigeru, Sawa, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688015/ https://www.ncbi.nlm.nih.gov/pubmed/36354516 http://dx.doi.org/10.3390/bioengineering9110605 |
Ejemplares similares
-
Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy
por: Sawa, Yoshiki, et al.
Publicado: (2013) -
Engineered three-dimensional cardiac tissues maturing in a rotating wall vessel bioreactor remodel diseased hearts in rats with myocardial infarction
por: Nakazato, Taro, et al.
Publicado: (2022) -
hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery
por: Li, Junjun, et al.
Publicado: (2020) -
Tissue Sheet Engineered Using Human Umbilical Cord-Derived Mesenchymal Stem Cells Improves Diabetic Wound Healing
por: Zhang, Jingbo, et al.
Publicado: (2022) -
Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease
por: Miyake, Keisuke, et al.
Publicado: (2022)